Vincerx Pharma, Inc. Stock-Based Compensation
Vincerx Pharma, Inc. reported Stock-Based Compensation of $435.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-15
- Vincerx Pharma, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $435.00K, a 17.61% decline year-over-year.
- Vincerx Pharma, Inc. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $610.00K, a 33.48% increase year-over-year.
- Vincerx Pharma, Inc. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $1.42M, a 126.23% increase year-over-year.
- Vincerx Pharma, Inc. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $912.00K, a 16.56% decline year-over-year.
- Vincerx Pharma, Inc. share-based payment arrangement, expense for fiscal 2024 was $3.47M, a 2.53% decline from fiscal 2023.
- Vincerx Pharma, Inc. share-based payment arrangement, expense for fiscal 2023 was $3.56M, a 64.57% decline from fiscal 2022.
- Vincerx Pharma, Inc. share-based payment arrangement, expense for fiscal 2022 was $10.06M, a 56.87% decline from fiscal 2021.
- Vincerx Pharma, Inc. share-based payment arrangement, expense for fiscal 2021 was $23.31M, a 432.02% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | $435.00K 10-Q · filed 2025-05-15 | $1.04M derived: sum of 2 quarters · filed 2025-05-15 | $2.47M derived: sum of 3 quarters · filed 2025-05-15 | $3.38M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-12-31 | $610.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.03M derived: sum of 2 quarters · filed 2025-03-27 | $2.94M derived: sum of 3 quarters · filed 2025-03-27 | $3.47M 10-K · filed 2025-03-27 | |||
| 2024-09-30 | $1.42M 10-Q · filed 2024-11-12 | $2.33M derived: sum of 2 quarters · filed 2024-11-12 | $2.86M 10-Q · filed 2024-11-12 | $3.32M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-06-30 | $912.00K 10-Q · filed 2024-08-08 | $1.44M 10-Q · filed 2024-08-08 | $1.90M derived: sum of 3 quarters · filed 2025-05-15 | $2.53M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-03-31 | $528.00K 10-Q · filed 2025-05-15 | $985.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.61M derived: sum of 3 quarters · filed 2025-05-15 | $2.71M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.09M derived: sum of 2 quarters · filed 2025-03-27 | $2.18M derived: sum of 3 quarters · filed 2025-03-27 | $3.56M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $629.00K 10-Q · filed 2024-11-12 | $1.34M 10-Q · filed 2023-11-14 | $1.72M derived: sum of 2 quarters · filed 2024-11-12 | $3.11M 10-Q · filed 2024-11-12 | $2.25M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $1.09M 10-Q · filed 2024-08-08 | $694.00K 10-Q · filed 2023-08-07 | $2.48M 10-Q · filed 2024-08-08 | $1.77M 10-Q · filed 2023-08-07 | $1.62M derived: sum of 3 quarters · filed 2024-08-08 | $3.91M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $1.38M 10-Q · filed 2024-05-14 | $1.07M 10-Q · filed 2023-05-11 | $530.00K derived: sum of 2 quarters · filed 2024-05-14 | $2.82M derived: sum of 3 quarters · filed 2024-05-14 | $6.18M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$854.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.44M derived: sum of 2 quarters · filed 2024-03-29 | $4.80M derived: sum of 3 quarters · filed 2024-03-29 | $10.06M 10-K · filed 2024-03-29 | $12.44M 10-K · filed 2023-03-28 | ||
| 2022-09-30 | $2.29M 10-Q · filed 2023-11-14 | $5.65M derived: sum of 2 quarters · filed 2023-11-14 | $10.91M 10-Q · filed 2023-11-14 | $16.80M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $3.36M 10-Q · filed 2023-08-07 | $8.62M 10-Q · filed 2023-08-07 | $14.51M derived: sum of 3 quarters · filed 2023-08-07 | $20.58M derived: sum of 4 quarters · filed 2023-08-07 | |||
| 2022-03-31 | $5.26M 10-Q · filed 2023-05-11 | $11.14M derived: sum of 2 quarters · filed 2023-05-11 | $17.22M derived: sum of 3 quarters · filed 2023-05-11 | $23.86M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $11.96M derived: sum of 2 quarters · filed 2023-03-28 | $18.60M derived: sum of 3 quarters · filed 2023-03-28 | $23.31M 10-K · filed 2023-03-28 | |||
| 2021-09-30 | $6.08M 10-Q · filed 2022-11-10 | $12.71M derived: sum of 2 quarters · filed 2022-11-10 | $17.43M 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | $6.64M 10-Q · filed 2022-08-11 | $11.35M 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | $4.71M 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | $4.38M 10-K · filed 2022-03-29 |